X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

- test

Finasteride Does Not Increase Risk for Prostate Cancer Death

Previously, the Prostate Cancer Prevention Trial showed finasteride increased the number of high-grade prostate cancers, even as it reduced patients’ overall... Read More

FDA Approves Yonsa for Metastatic Castration-Resistant Prostate Cancer

The FDA approved a novel formulation of abiraterone acetate in combination with methylprednisolone for the treatment of patients with metastatic castration-resistant... Read More

MRI-Based Prediction Model May Reduce Unnecessary Biopsies in Prostate Cancer

Including MRI-derived parameters in a prediction model reduced the number of unnecessary biopsies while still detecting a high rate of... Read More

Greater Ejaculation Frequency May Reduce Prostate Cancer Risk

Ten-year follow-up data from a prospective cohort study add to prior evidence that suggested more frequent ejaculation may reduce prostate... Read More

Prostate Cancer Screening Rates Vary Significantly by State

Adherence to the U.S. Preventive Services Task Force 2011 recommendations on PSA screening differed significantly from state to state, according... Read More

Metastasis-Free Survival Viable Endpoint for Prostate Cancer Trials

Metastasis-free survival could be a surrogate endpoint for OS in clinical trials designed to evaluate adjuvant therapy options for patients... Read More

Platinum-Based Chemotherapy Shows Efficacy in BRCA2-Mutated Prostate Cancer

A small group of men with metastatic, castration-resistant prostate cancer who carried a BRCA2 mutation responded favorably to platinum-based chemotherapy... Read More

Diabetes Does Not Affect Overall Survival in Prostate Cancer

Among men with prostate cancer, diabetes status did not significantly affect 5-year overall survival, according to findings published in Endocrine... Read More

Memorial Sloan Kettering Cancer Center to Study Photodynamic Therapy for Multiple Tumor Types

Researchers at Memorial Sloan Kettering Cancer Center have initiated several studies to assess photodynamic therapy for patients with prostate, esophageal,... Read More

Direct-to-Consumer Genetic Testing Does Not Improve Habits in High-Risk Adults

Most adults who received elevated direct-to-consumer personal genomic testing to detect risk for single nucleotide polymorphism–based cancer were not more... Read More

1 2 3